Fact checked by Nick Blackmer Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the ...

The FDA is recalling 30-count, 90-count and 1000-count bottles of duloxetine that contain 60 mg capsules. In total, 233,003 bottles are being recalled. That does not include the 7,107 bottles ...

In October, more than 7,000 bottles of 500-count 20 mg duloxetine delayed-release capsules produced by Towa Pharmaceutical Europe were also recalled over the potential presence of N-nitroso ...

The capsules of duloxetine were first recalled in November, but the FDA recently categorized the recall as a Class II risk, a situation in which "use of or exposure to a violative product may ...

More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II risk ...

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...